Organization
Beijing Jishuitan Hospital
1 clinical trial
2 abstracts
Abstract
Clinical observation study of recombinant human thrombopoietin in the prevention of chemotherapy-induced thrombocytopenia in patients with aggressive lymphoma.Org: Beijing Tong-Ren Hospital, Beijing Luhe Hospital Capital Medical University, Langfang Traditional Chinese Medicine Hospital, Fuxing Hospital Capital Medical University, Beijing Jishuitan Hospital,
Clinical trial
Prospective Randomized Controlled Study on Arthroscopic Treatment Combined With PRP Injection for Refractory Elbow EpicondylitisStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Abstract
A phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors.Org: Fudan University Shanghai Cancer Center, Department of Orthopedics, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology ,ZheJiang provincial people’s hospital, Department of Oral and Maxillofacial Head & Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China,